DERMATA THERAPEUTICS, INC. Income Taxes Paid
DERMATA THERAPEUTICS, INC. (DRMA) reported Income Taxes Paid of $950 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-03-26
- DERMATA THERAPEUTICS, INC. income taxes paid for the quarter ending 2025-12-31 was $0.00.
- DERMATA THERAPEUTICS, INC. income taxes paid for the quarter ending 2025-09-30 was $0.00.
- DERMATA THERAPEUTICS, INC. income taxes paid for the quarter ending 2024-12-31 was $0.00.
- DERMATA THERAPEUTICS, INC. income taxes paid for the quarter ending 2024-09-30 was $0.00.
- DERMATA THERAPEUTICS, INC. income taxes paid for fiscal 2025 was $950.00, a 0.00% change from fiscal 2024.
- DERMATA THERAPEUTICS, INC. income taxes paid for fiscal 2024 was $950.00, a 0.00% change from fiscal 2023.
- DERMATA THERAPEUTICS, INC. income taxes paid for fiscal 2023 was $950.00, a 0.00% change from fiscal 2022.
- DERMATA THERAPEUTICS, INC. income taxes paid for fiscal 2022 was $950.00, a 32.14% decline from fiscal 2021.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $950.00 10-K · filed 2026-03-26 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $950.00 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | $950.00 10-Q · filed 2025-08-13 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $950.00 10-K · filed 2026-03-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $950.00 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $950.00 10-Q · filed 2025-08-13 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $0.00 derived: sum of 2 quarters · filed 2025-03-17 | $950.00 10-K · filed 2025-03-17 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $950.00 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | $950.00 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $150.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $150.00 derived: sum of 2 quarters · filed 2024-03-21 | $950.00 derived: sum of 3 quarters · filed 2024-03-21 | $950.00 10-K · filed 2024-03-21 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $800.00 derived: sum of 2 quarters · filed 2023-11-09 | $800.00 10-Q · filed 2023-11-09 | $800.00 derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $800.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $800.00 10-Q · filed 2022-08-15 | $800.00 derived: sum of 3 quarters · filed 2023-02-21 | $800.00 derived: sum of 4 quarters · filed 2023-02-21 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2023-02-21 | $0.00 derived: sum of 3 quarters · filed 2023-02-21 | $450.00 derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $0.00 derived: sum of 2 quarters · filed 2023-02-21 | $450.00 derived: sum of 3 quarters · filed 2023-02-21 | $1.40K 10-K · filed 2023-02-21 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $450.00 derived: sum of 2 quarters · filed 2022-11-10 | $1.40K 10-Q · filed 2022-11-10 | $3.27K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $450.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.40K 10-Q · filed 2022-08-15 | $3.27K derived: sum of 3 quarters · filed 2022-08-15 | $3.27K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $950.00 10-Q · filed 2022-05-16 | $2.82K derived: sum of 2 quarters · filed 2022-05-16 | $2.82K derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $1.87K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $1.87K derived: sum of 2 quarters · filed 2022-03-28 | $3.27K 10-K · filed 2022-03-28 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.40K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $1.40K 10-Q · filed 2021-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |